Target intelligence / Profile preview

Bile acid metabolism regulation

Molecular classification
Nuclear receptor, G protein-coupled receptor, Enzyme, Transporter
01

Overview

Bile acid metabolism regulation is a complex physiological system that maintains the balance of bile acids within the enterohepatic circulation, serving critical roles in lipid digestion and systemic signaling [1][2]. The process is primarily governed by the farnesoid X receptor (FXR), which acts as a molecular sensor for bile acids to regulate their synthesis, transport, and detoxification [1][3]. When bile acid levels are high, FXR suppresses the rate-limiting enzyme cholesterol 7α-hydroxylase (CYP7A1) via the induction of fibroblast growth factor 19 (FGF19) [3][5]. Beyond the liver, bile acids interact with the G protein-coupled receptor TGR5 to modulate glucose metabolism and inflammatory responses [3]. Dysregulation of this metabolic control is central to the development of cholestatic diseases like primary biliary cholangitis and metabolic disorders such as non-alcoholic steatohepatitis (NASH) [2][4]. Therapeutic interventions target various nodes of this regulation, including FXR agonists to reduce bile acid pools and ASBT inhibitors to prevent intestinal reabsorption, aiming to alleviate cholestasis and improve metabolic health [4][5].

Other names
Bile acid homeostasisBile acid signaling pathwayEnterohepatic circulation of bile acids
02

Mechanism of action

The regulation of bile acid metabolism is achieved through several mechanisms: activation of the farnesoid X receptor (FXR) which induces FGF19 to suppress hepatic CYP7A1-mediated bile acid synthesis; inhibition of the apical sodium-dependent bile acid transporter (ASBT) to reduce enterohepatic recirculation; and activation of the TGR5 receptor to enhance GLP-1 secretion and energy expenditure [1][3][5].

03

Biological functions

Lipid metabolismCholesterol homeostasisGlucose metabolismEnergy homeostasis
04

Disease associations

Primary biliary cholangitisNon-alcoholic steatohepatitisCholestasisMetabolic syndromePrimary sclerosing cholangitis
05

Safety considerations

PruritusIncreased LDL cholesterolHepatotoxicityGastrointestinal distress
06

Interacting drugs

Obeticholic acid

5 more in the full profile.

07

Biomarkers

Serum bile acids7α-hydroxy-4-cholesten-3-one (C4)Fibroblast growth factor 19 (FGF19)

Beyond the preview

Go deeper on Bile acid metabolism regulation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bile acid metabolism regulation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call